Morikazu Miyamoto

No ORCID on file · 4 papers in corpus · active 2016-2021

Study types

  • article 3
  • other 1

Condition tags

  • endometriosis 4
article 2021
Clear cell borderline tumor without fibromatous component: Pathological and literature review and report of two cases
Molecular and clinical oncology ·doi:10.3892/mco.2021.2237

The aim of the present study was to examine the clinical outcome of ovarian clear cell borderline tumor (CCBT) through pathological review for cases with clear cell carcinoma (CCC) and CCBT between 1984 and 2015 who received surgery at the …

other 2020
Ovarian Seromucinous Borderline Tumors Are Histologically Different from Mucinous Borderline Tumors
In vivo (Athens, Greece) ·doi:10.21873/invivo.11911

AIM: To examine the clinicopathological features of ovarian seromucinous borderline tumors (SMBTs) and compare them with those of mucinous borderline/atypical proliferative mucinous tumors (MB/APMTs). PATIENTS AND METHODS: Patients with SM…

article 2017
Role of endometriosis as a prognostic factor for post‑progression survival in ovarian clear cell carcinoma
Molecular and clinical oncology ·doi:10.3892/mco.2017.1468

The clinical significance of coexistence of endometriosis (EM) in ovarian clear cell carcinoma (CCC) has not yet been determined. The aim of the present study was to analyze the correlation of endometriosis with clinicopathological factors …

article 2016
Effect of ARID1A/BAF250a expression on carcinogenesis and clinicopathological factors in pure-type clear cell adenocarcinoma of the ovary
Molecular and clinical oncology ·doi:10.3892/mco.2016.973

gene remains to be determined. The aim of the present study was to assess whether BAF250a expression had an impact on the clinical features of CCA. A total of 97 cases of CCA treated at a single institution were enrolled in the present stud…